109
Participants
Start Date
April 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
February 28, 2014
PBT2
250mg capsules administered orally once per day for 26 weeks
PBT2
100mg capsules administered orally once per day for 26 weeks
Placebo
Matching capsules administered orally once per day for 26 weeks
Westmead Hospital, Sydney
Royal Melbourne Hospital, Parkville
University of Melbourne Normanby Unit - St Vincents/St Georges, Melbourne
Calvary Health Care Bethlehem, Clayton
Neurodegenerative Disorders Research, Perth
Columbia University Medical Center, New York
Albany Medical College, Albany
University of Maryland School of Medicine, Baltimore
Johns Hopkins University, Baltimore
University of Miami, Miami
University of Tennessee Health Science Center, Memphis
Ohio State University Medical Center, Columbus
Struthers Parkinson's Center, Golden Valley
Washington University, St Louis
Colorado Neurological Institute, Englewood
University of California San Diego, San Diego
Booth Gardner Parkinson's Care Center, Kirkland
University of Connecticut Health Center, Farmington
Massachusetts General Hospital East, Charlestown
Lead Sponsor
Prana Biotechnology Limited
INDUSTRY